Jurisdictions:
Languages:
English
Biography
Tyson is a senior patent and trade marks attorney at Wrays where he has worked since 2010. He specialises in helping clients align their patent portfolios with broader commercial strategies, ensuring intellectual property adds tangible value to their business. Tyson has extensive experience drafting and prosecuting patent applications, as well as providing infringement, validity and freedom-to-operate opinions across a diverse range of industries.
With a technical background in chemistry and physics, Tyson focuses on nanoparticulate substances and applies his expertise to industries including mineral processing, nanotechnology, hydrometallurgy, and upstream and downstream oil and gas processing. He works with a wide range of clients, from individual inventors and start-ups to universities and large corporates, providing tailored strategic IP advice that supports innovation and commercial growth.
Tyson is highly active in the innovation and technology transfer communities in Australia and New Zealand. He is a past regional chair of the Western Australian Licensing Executives Society of Australia & New Zealand (LESANZ) committee and is the judge for the 2025 and 2026 Business News 40under40 Awards, recognising leading entrepreneurs, innovators and future business leaders in Western Australia.
His industry expertise spans chemistry and material sciences, extractive metallurgy and process technology, chemical engineering, resources, mining, oil and gas, pharmaceutical and medical technologies.
Tyson is recognised as a Notable Practitioner by IP Stars from 2022 through 2025, reflecting his standing as a leading advisor in intellectual property strategy, patent prosecution and innovation-driven commercialisation.
With a technical background in chemistry and physics, Tyson focuses on nanoparticulate substances and applies his expertise to industries including mineral processing, nanotechnology, hydrometallurgy, and upstream and downstream oil and gas processing. He works with a wide range of clients, from individual inventors and start-ups to universities and large corporates, providing tailored strategic IP advice that supports innovation and commercial growth.
Tyson is highly active in the innovation and technology transfer communities in Australia and New Zealand. He is a past regional chair of the Western Australian Licensing Executives Society of Australia & New Zealand (LESANZ) committee and is the judge for the 2025 and 2026 Business News 40under40 Awards, recognising leading entrepreneurs, innovators and future business leaders in Western Australia.
His industry expertise spans chemistry and material sciences, extractive metallurgy and process technology, chemical engineering, resources, mining, oil and gas, pharmaceutical and medical technologies.
Tyson is recognised as a Notable Practitioner by IP Stars from 2022 through 2025, reflecting his standing as a leading advisor in intellectual property strategy, patent prosecution and innovation-driven commercialisation.
- Year joined firm: 2010
Recent matter / case highlights
- Neometals Ltd: Wrays acts for Neometals Ltd, a leading Australian minerals and advanced materials developer listed on the Australian and London Stock Exchanges, advising on patent drafting, filing, and prosecution for Neometals and its subsidiaries. Wrays manages over 45 patent applications across eight families, covering technologies in lithium refining, battery recycling, zeolite synthesis and titanium and vanadium processing. Services include freedom-to-operate and novelty opinions, as well as strategic IP portfolio development. By capturing the commercial advantages of Neometals’ innovations, Wrays supports the company’s international growth and its positioning in critical materials markets, particularly lithium-ion battery technologies with global demand and commercial potential.
- Talga Resources Ltd: Wrays advises Talga, a developer of graphene and nanographite technologies, on comprehensive IP management and strategy. Wrays assisted in developing tailored practices and procedures covering IP identification, protection, ownership, disclosure management, confidentiality, licensing, employment agreements, monitoring, third-party rights, and IP education. Acting as Talga’s primary patent attorneys, Wrays also provides patent drafting, filing, and prosecution services, supporting key innovations and commercial strategies. Additional services include advice on IP protection, enforcement, trade mark matters, and monitoring of the IP landscape. Wrays’ work strengthens Talga’s IP framework, ensuring robust protection and enabling the commercialisation of its advanced nanographitic technologies.
- Bunnings Group Limited: Wrays plays a key role in managing Bunnings' intellectual property portfolio, offering comprehensive trade mark portfolio management and strategic guidance across Australia, New Zealand, China, the Pacific, the United Kingdom, and Ireland. The work encompasses the ongoing oversight of more than 650 trade mark registrations and includes 175 active filings. Wrays also provides advice on potential trade mark and copyright infringements, strategic commercial matters, competitor trade mark monitoring, and enforcement actions where necessary.
Key practice areas
- Intellectual property (prosecution)
- Patent
- Patent (prosecution)
Sector expertise
- Chemical
- Construction and materials
- Industrials
- Nanotechnology
- Natural resources
Education / Alumni
- Bachelor of Science (Honours) in Nanotechnology
- Masters of Industrial Property
Association / Network Memberships
- IPTA (The Institute of Patent and Trade Mark Attorneys of Australia) (2012)
- Licensing Executives Society of Australia & New Zealand (Past Chairperson – WA Regional Committee)
Address:
Tel:+61 8 9216 5100
Email:Contact this practitioner
Website:https://wrays.com.au/our-people/tyson-keed/
Level 7, 863 Hay Street
Perth, Western Australia, 6000
Australia
Related Practitioners
-
Grant has over 20 years’ experience providing strategic intellectual property advice to top-tier global pharmaceutical clients, including Merck, Amgen, Johnson & Johnson, Nestle, CRISPR Therapeutics and Zoetis. His expertise spans patent drafting and prosecution across molecular and cell biology, immunology, pharmaceuticals, cell and gene therapy, medical devices and diagnostics. He has extensive experience managing patent oppositions, including five concurrent Australian oppositions forming part of the global CRISPR gene editing litigation, and possesses specialist knowledge in securing pharmaceutical patent term extensions and advising on patent validity and infringement. His litigation support experience includes revocation proceedings in the Federal Court, including matters concerning blockbuster biologics.
-
Natalie Shoolman is a Principal and the Head of IP Litigation & Dispute Resolution at Wrays, based in Sydney, Australia.
-
-
-